Orgenesis Stock Buy Hold or Sell Recommendation

ORGS Stock  USD 0.85  0.05  5.56%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Orgenesis is 'Not Rated'. Macroaxis provides Orgenesis buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ORGS positions. The advice algorithm takes into account all of Orgenesis' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Orgenesis' buy or sell advice are summarized below:
Real Value
0.0
Hype Value
0.0
Market Value
0.85
Naive Value
0.78
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Orgenesis given historical horizon and risk tolerance towards Orgenesis. When Macroaxis issues a 'buy' or 'sell' recommendation for Orgenesis, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Orgenesis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.
In addition, we conduct extensive research on individual companies such as Orgenesis and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Execute Orgenesis Buy or Sell Advice

The Orgenesis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Orgenesis. Macroaxis does not own or have any residual interests in Orgenesis or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Orgenesis' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell OrgenesisBuy Orgenesis
Strong Sell

Market Performance

OKDetails

Volatility

Out of controlDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Almost neglects market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Orgenesis has a Mean Deviation of 5.98, Semi Deviation of 5.76, Standard Deviation of 9.08, Variance of 82.53, Downside Variance of 59.01 and Semi Variance of 33.23
We provide trade recommendations to complement the recent expert consensus on Orgenesis. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Orgenesis is not overpriced, please check all Orgenesis fundamentals, including its debt to equity, total asset, and the relationship between the ebitda and earnings per share . As Orgenesis appears to be a penny stock we also advise to check out its price to earning numbers.

Orgenesis Trading Alerts and Improvement Suggestions

Orgenesis is way too risky over 90 days horizon
Orgenesis has some characteristics of a very speculative penny stock
Orgenesis appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 27.75 M. Net Loss for the year was (21.85 M) with profit before overhead, payroll, taxes, and interest of 36.02 M.
Orgenesis currently holds about 2.3 M in cash with (25.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Roughly 21.0% of the company outstanding shares are owned by corporate insiders

Orgenesis Returns Distribution Density

The distribution of Orgenesis' historical returns is an attempt to chart the uncertainty of Orgenesis' future price movements. The chart of the probability distribution of Orgenesis daily returns describes the distribution of returns around its average expected value. We use Orgenesis price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Orgenesis returns is essential to provide solid investment advice for Orgenesis.
Mean Return
1.25
Value At Risk
-12.36
Potential Upside
14.63
Standard Deviation
9.08
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Orgenesis historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Orgenesis Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Orgenesis or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Orgenesis' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Orgenesis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
1.26
β
Beta against NYSE Composite-0.2
σ
Overall volatility
9.08
Ir
Information ratio 0.12

Orgenesis Volatility Alert

Orgenesis is displaying above-average volatility over the selected time horizon. Orgenesis is a potential penny stock. Although Orgenesis may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Orgenesis. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Orgenesis instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Orgenesis Fundamentals Vs Peers

Comparing Orgenesis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Orgenesis' direct or indirect competition across all of the common fundamentals between Orgenesis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Orgenesis or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Orgenesis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Orgenesis to competition
FundamentalsOrgenesisPeer Average
Return On Equity-1.02-0.31
Return On Asset-0.0898-0.14
Profit Margin(0.90) %(1.27) %
Operating Margin(20.32) %(5.51) %
Current Valuation50.76 M16.62 B
Shares Outstanding34.15 M571.82 M
Shares Owned By Insiders20.91 %10.09 %
Shares Owned By Institutions6.70 %39.21 %
Number Of Shares Shorted225.71 K4.71 M
Price To Earning7.52 X28.72 X
Price To Book2.34 X9.51 X
Price To Sales1.11 X11.42 X
Revenue27.75 M9.43 B
Gross Profit36.02 M27.38 B
EBITDA(16.12 M)3.9 B
Net Income(21.85 M)570.98 M
Cash And Equivalents2.3 M2.7 B
Cash Per Share0.09 X5.01 X
Total Debt20.27 M5.32 B
Debt To Equity0.64 %48.70 %
Current Ratio1.57 X2.16 X
Book Value Per Share0.41 X1.93 K
Cash Flow From Operations(25.1 M)971.22 M
Short Ratio1.03 X4.00 X
Earnings Per Share(0.86) X3.12 X
Target Price6.0
Number Of Employees16718.84 K
Beta1.04-0.15
Market Capitalization30.7 M19.03 B
Total Asset90.93 M29.47 B
Retained Earnings(121.26 M)9.33 B
Working Capital30.41 M1.48 B
Current Asset5.29 M9.34 B
Note: Acquisition by Neil Reithinger of 16667 shares of Orgenesis at 6.0 subject to Rule 16b-3 [view details]

Orgenesis Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Orgenesis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Orgenesis Buy or Sell Advice

When is the right time to buy or sell Orgenesis? Buying financial instruments such as Orgenesis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Orgenesis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Thematic Idea Now

Obamacare
Obamacare Theme
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Orgenesis is a strong investment it is important to analyze Orgenesis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orgenesis' future performance. For an informed investment choice regarding Orgenesis Stock, refer to the following important reports:
Check out Orgenesis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Orgenesis Stock analysis

When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.